What we do Astal Laboratories Ltd manufactures pharmaceutical intermediates and bulk drugs, catering to growing global demand for essential pharma ingredients. |
Founded in 1,993 |
Market share Emerging player in pharmaceutical bulk drugs, rapidly expanding operations and market presence after 2024 pivot. |
Problem solved Addresses global need for high-quality active pharmaceutical ingredients and intermediates critical for medicine production. |
Top clients or who we serve Supplies pharmaceutical companies globally; primarily B2B with focus on pharma manufacturers. |
Key management - |
Our journey and innovations Originally Macro International till 2024, shifted focus to pharmaceuticals in FY2025; witnessed significant revenue growth of 171%. |
Where we operate Operations mainly in India with growing global client base, exports under development. |
Top products or what we offer Manufacture of pharmaceutical bulk drugs, active pharma ingredients, and key starting materials. |
Top brands - |
Raw materials needed Chemical raw materials used in manufacturing pharma intermediates and bulk drugs. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue largely recurring from ongoing pharma ingredient contracts. |
Our industry position New entrant but growing rapidly in pharmaceutical bulk drug manufacturing sector. |
Financial highlights FY2025 revenue Rs. 64.23 crore, PAT Rs. 8.93 crore, over 1000% profit growth YoY. |
Geographical revenue split - |
Order book - |
Whats driving growth Demand for pharma ingredients, strategic focus shift, growing manufacturing capabilities. |
Our future plans Expansion of production capacity and product portfolio in pharmaceutical intermediates and APIs. |
Our green promise - |
Our people and values Focuses on employee engagement, structured communication for growth and development. |
Key challenges ahead Scaling manufacturing efficiently, meeting global compliance and competition in pharma ingredients. |
Interesting facts Company transformed from retail to pharma manufacturing with strong recent growth. |
Risks and strategy Managing risks through compliance, quality controls, and strategic investments. |
